🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the efficacy and safety of ombitasvir/paritaprevir/rit...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-30
Trial ID
NCT02487199
Treatments Being Tested
The purpose of this study is to evaluate the safety and antiviral activity ...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01674725
Treatments Being Tested
There is compelling data supporting the pursuit of research into the effect...
Status
Completed
Location
The Ottawa Hospital, General Campus
Start Date
2015-07
Trial ID
NCT02734173
Treatments Being Tested
The interferon-free combination regimen of paritaprevir/r - ombitasvir with...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-03
Trial ID
NCT02615145
To evaluate the effect of ribavirin on second phase plasma hepatitis C viru...
Status
Completed
Location
Multiple Locations
Start Date
2015-06
Trial ID
NCT02493855
Treatments Being Tested
Hepatitis C virus (HCV) infection is common in patients receiving hemodialy...
Status
Completed
Location
Ditmanson Medical Foundation Chia-Yi Christian Hospital
Start Date
2017-03-13
Trial ID
NCT02874066
Treatments Being Tested
Post-marketing surveillance study to evaluate the real world safety and eff...
Status
Completed
Location
Dong-A University Hospital /ID# 167362
Start Date
2017-08-17
Trial ID
NCT03201718
The interferon-free combination regimen of ombitasvir/paritaprevir/ritonavi...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-07
Trial ID
NCT02581163
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Site Reference ID/Investigator# 20081
Start Date
2009-05
Trial ID
NCT00909636
This open-label study will evaluate the safety and efficacy of co-formulate...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02399345
Treatments Being Tested